2020 brought unprecedented challenges and disruption to the life
sciences sector, as labs around the world joined the race to control
the spread of SARS-CoV-2. From virology research to drug discovery
and clinical diagnostics, the community came together to understand
the virus and accelerate the development and manufacture of new
vaccines. The need for high throughput testing, increased biosafety and
physical distancing of staff meant that many labs have had to rethink
the way they operate, and Tecan has been at the forefront of this effort.
Our laboratory automation and software solutions have been providing
the throughput, reproducibility and user safety necessary for large
scale diagnostic screening and vaccine development, supported by
our incredibly dedicated global team of experts.